These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11812078)

  • 1. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study.
    Brummer O; Böhmer G; Hollwitz B; Flemming P; Petry KU; Kühnle H
    Gynecol Oncol; 2002 Feb; 84(2):222-7. PubMed ID: 11812078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
    Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Weis B; Ben-Baruch G; Reich R
    Gynecol Oncol; 1999 Mar; 72(3):380-6. PubMed ID: 10053110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
    Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
    Anticancer Res; 2006; 26(2B):1543-56. PubMed ID: 16619570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry.
    Davidson B; Goldberg I; Gotlieb WH; Ben-Baruch G; Kopolovic J
    Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):109-14. PubMed ID: 9481557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma.
    Gaiotto MA; Focchi J; Ribalta JL; Stávale JN; Baracat EC; Lima GR; Guerreiro da Silva ID
    Am J Obstet Gynecol; 2004 May; 190(5):1278-82. PubMed ID: 15167830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY; Yao JF; Chen XD
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation.
    Talvensaari A; Apaja-Sarkkinen M; Höyhtyä M; Westerlund A; Puistola U; Turpeenniemi T
    Gynecol Oncol; 1999 Mar; 72(3):306-11. PubMed ID: 10053100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
    Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
    Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix.
    Nasr M; Ayyad SB; El-Lamie IK; Mikhail MY
    Eur J Gynaecol Oncol; 2005; 26(2):199-202. PubMed ID: 15857029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
    Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
    Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix.
    Saegusa M; Takano Y; Hashimura M; Shoji Y; Okayasu I
    Cancer; 1995 Dec; 76(11):2297-303. PubMed ID: 8635035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
    Bonds L; Baker P; Gup C; Shroyer KR
    Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early acquisition of gelatinolytic activity in carcinogenesis of the uterine cervix.
    Minami R; Tsunoda H; Iijima T; Yoshikawa H; Nemori R; Noguchi M
    Mod Pathol; 2003 Nov; 16(11):1164-70. PubMed ID: 14614057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.
    Lai HC; Chu CM; Lin YW; Chang CC; Nieh S; Yu MH; Chu TY
    Gynecol Oncol; 2005 Feb; 96(2):314-9. PubMed ID: 15661214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
    Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Ben-Baruch G; Reich R
    Gynecol Oncol; 1999 Jun; 73(3):372-82. PubMed ID: 10366463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
    Akasofu M; Oda Y
    Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities.
    Hopman AH; Smedts F; Dignef W; Ummelen M; Sonke G; Mravunac M; Vooijs GP; Speel EJ; Ramaekers FC
    J Pathol; 2004 Jan; 202(1):23-33. PubMed ID: 14694518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
    Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
    J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.